News
-
Female leaders step into new roles
- Mon Sep 28
Surge of senior promotions and appointments favours female leaders across Australian pharma as an Aussie star continues her rise at J&J EMEA.
Read more -
China-US tensions close in on Australia
- Mon Sep 28
As China looks to dominate innovative R&D, Australia must decide where it sits in the New World Order, and what it will pay to make that happen.
Read more -
Dengue travel vax gets ATAGI approval
- Mon Sep 28
Takeda’s dengue Qdenga offers travellers a new layer of protection against a disease that shadows popular holiday destinations.
Read more -
Boehringer is moving, but will stay in Pill Hill
- Fri Sep 25
Boehringer Ingelheim is defying the trend away from Pill Hill, announcing it is moving – but will stay in Macquarie Park.
Read more -
Industry awards: correlation or causation?
- Fri Sep 25
OP-ED: Is the amount someone pays an industry awards organiser and their chance of picking up an award correlation, or causation?
Read more -
Lilly set to disrupt medicines supply chain
- Wed Sep 23
LillyDirect may well be to community pharmacy what Uber was to taxis; taxis are still there, but if given a choice, most people choose Uber.
Read more -
AstraZeneca to keep Zoladex on PBS longer
- Wed Sep 23
AstraZeneca will keep Zoladex on the PBS for another six months but after that, the product will be withdrawn from Australia.
Read more -
Patients asked back to HTA reform table
- Wed Sep 23
Despite having made endless contributions over the past seven years, the Department is asking patients to return to the table – again.
Read more